The largest ever global study of tuberculosis has identified all the mutations conferring resistance to approved antimicrobials, setting the scene for more rational use of drugs, increasing mechanistic understanding of how Mycobacteriumtuberculosis develops resistance to antibiotics and pointing to new drug targets.
